BioSpace News Archive

Healogics Specialty Physician Care Continuum Program will increase the consistency, quality and speed of patient care through dedicated, focused physician leadership and clinical processes

A group of digital influencers from across the country will partner with St. Jude Children’s Research Hospital© for Childhood Cancer Awareness Month, engaging with their followers to build awareness and help end childhood cancer.

UPMC Health Plan announced today a value-based contract with Alkermes for VIVITROL® (naltrexone for extended-release injectable suspension).

CloudLIMS, a Laboratory Information Management System (LIMS), and Confident CannabisTM, a software for labs and all members of the cannabis supply chain, now offer an integrated solution that provides cannabis testing laboratories with a robust testing, analytical, and reporting tool.

Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 20th Annual Global Investment Conference,

Gilead Sciences, Inc. today announced that John F. Milligan PhD, Gilead’s President and Chief Executive Officer; Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer, and John McHutchison, AO, MD, Gilead’s Chief Scientific Officer will participate in at the Morgan Stanley Global Healthcare Conference.

GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today commented on a paper published by Iampietro et al, from the Department of Pathology, University of Texas Medical Branch at Galveston, Texas, in The Journal of Infectious Diseases, concerning new findings on how the Ebola virus (EBOV) disables the host immune system and spreads infection.

Nevro Corp. today announced the company will be participating in the upcoming Morgan Stanley Global Healthcare Conference in New York, NY.

Five Prime Therapeutics, Inc. (Nasdaq: FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that Aron Knickerbocker, Chief Executive Officer, will present at the 2018 Wells Fargo Healthcare Conference, Sept. 6, 2018, at 2:30 pm

One in 10 people suffer from the debilitating effects of Plantar Fasciitis at least once in their lives.